首页> 外国专利> METHOD OF DETERMINING TACTICS OF PATIENTS MANAGEMENT IN CASE OF PRETERM LABOUR, COMPLICATED WITH PRETERM RUPTURE OF MEMBRANES

METHOD OF DETERMINING TACTICS OF PATIENTS MANAGEMENT IN CASE OF PRETERM LABOUR, COMPLICATED WITH PRETERM RUPTURE OF MEMBRANES

机译:确定早产劳动情况下确定患者治疗策略的方法,并与早产膜破裂有关

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to obstetrics and deals with determination of tactics of management in case of incomplete pregnancy, complicated with preterm rupture of membranes (PRM). Seven day course of antibacterial therapy is carried out, after that, on a daily basis carried out is estimation of amniotic fluid index (AFI) and presence of clinical sign of infection. If AFI values are higher than 8 cm and clinical signs of infection are absent, course of antibacterial therapy is not repeated. If AFI values are lower than 5 cm and in case of absence or presence of clinical signs of infection, course of antibacterial therapy is repeated, further management of pregnancy is carried out according to obstetric indications. In case if AFI is from 5 to 8 cm and no clinical signs of infection are present, clinical-laboratory examination is performed, including estimation of general state, thermometry, estimation of parametres of mother's hemodynamics, vaginal secretions, clinical blood test, concentration of C-reactive protein in blood serum. In case if data testifying to presence of infectious process are obtained, course of antibiotic therapy is repeated.;EFFECT: method ensures possibility to predict development of purulent-septic complications, differentiated selection of tactics of management of incomplete pregnancy, complicated with PRM, and early beginning of treatment, and as a result, reduction of complication frequency.;3 ex
机译:技术领域本发明涉及医学,即涉及产科,并用于确定妊娠不完全,并发胎膜早破(PRM)的情况下的治疗策略。进行为期7天的抗菌治疗,然后每天评估羊水指数(AFI)和临床感染征象。如果AFI值高于8 cm,并且没有感染的临床征兆,则不重复进行抗菌治疗。如果AFI值低于5 cm,并且在没有或没有临床感染迹象的情况下,重复进行抗菌治疗,则根据产科适应症进一步进行妊娠治疗。如果AFI为5到8 cm,并且没有感染的临床征兆,则进行临床实验室检查,包括一般状况的估计,体温测定,母亲血液动力学参数的估计,阴道分泌物,临床血液检查,血清中的C反应蛋白。如果获得证明存在感染过程的数据,则重复抗生素治疗的过程。效果:该方法可确保预测化脓性并发症的发生,区分不完全妊娠,PRM并发的处理策略的差异选择以及尽早开始治疗,因此减少了并发症的发生频率; 3 ex

著录项

  • 公开/公告号RU2408263C2

    专利类型

  • 公开/公告日2011-01-10

    原文格式PDF

  • 申请/专利权人 KOZLOV PAVEL VASILEVICH;

    申请/专利号RU20090137226

  • 发明设计人 KOZLOV PAVEL VASILEVICH;

    申请日2009-10-08

  • 分类号A61B5/1482;A61K31/547;A61P31/04;

  • 国家 RU

  • 入库时间 2022-08-21 17:48:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号